Search Results - JM Schecter

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESS... by H Einsele, AD Cohen, M Delforge, J Hillengass, H Goldschmidt, K Weisel, M-S Raab, C Scheid, JM Schecter, KC De Braganca, H Varsos, T-M Yeh, L Wang, M Vogel, C Corsale, M Akram, L Pacaud, T Nesheiwat, M Agha, YC Cohen

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  2. 2

    B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND E... by NWCJ van de Donk, M Delforge, M Agha, AD Cohen, YC Cohen, J Hillengass, S Anguille, T Kerre, W Roeloffzen, JM Schecter, KC De Braganca, H Varsos, L Wang, M Vogel, E Zudaire, C Corsale, M Akram, D Geng, T Nesheiwat, L Pacaud, P Sonneveld, S Zweegman

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  3. 3

    B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA by F Gay, JG Berdeja, V De Stefano, P Hari, B Hooper, A Haltner, S Kumar, T Martin, M-V Mateos, P Moreau, E Rosta, IA Samjoo, SZ Usmani, K Weisel, CC Jackson, Y Olyslager, JM Schecter, M Vogel, A Garrett, S Lee, T Nesheiwat, L Pacaud, C Zhou, S Valluri, LJ Costa, Y Lin

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


Search Tools: